Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults.

Sagara I, Healy SA, Assadou MH, Gabriel EE, Kone M, Sissoko K, Tembine I, Guindo MA, Doucoure M, Niaré K, Dolo A, Rausch KM, Narum DL, Jones DL, MacDonald NJ, Zhu D, Mohan R, Muratova O, Baber I, Coulibaly MB, Fay MP, Anderson C, Wu Y, Traore SF, Doumbo OK, Duffy PE.

Lancet Infect Dis. 2018 Sep;18(9):969-982. doi: 10.1016/S1473-3099(18)30344-X. Epub 2018 Jul 27.

2.

Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination trials in patients with cervical cancer in Mali.

Téguété I, Dolo A, Sangare K, Sissoko A, Rochas M, Beseme S, Tounkara K, Yekta S, De Groot AS, Koita OA.

PLoS One. 2017 Feb 23;12(2):e0172661. doi: 10.1371/journal.pone.0172661. eCollection 2017.

3.

Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial.

Sissoko MS, Healy SA, Katile A, Omaswa F, Zaidi I, Gabriel EE, Kamate B, Samake Y, Guindo MA, Dolo A, Niangaly A, Niaré K, Zeguime A, Sissoko K, Diallo H, Thera I, Ding K, Fay MP, O'Connell EM, Nutman TB, Wong-Madden S, Murshedkar T, Ruben AJ, Li M, Abebe Y, Manoj A, Gunasekera A, Chakravarty S, Sim BKL, Billingsley PF, James ER, Walther M, Richie TL, Hoffman SL, Doumbo O, Duffy PE.

Lancet Infect Dis. 2017 May;17(5):498-509. doi: 10.1016/S1473-3099(17)30104-4. Epub 2017 Feb 16.

PMID:
28216244
4.

Socio-demographic and reproductive determinants of cervical neoplasia in seven sub-Sahara African countries.

Muwonge R, Ngo Mbus L, Ngoma T, Gombe Mbalawa C, Dolo A, da Ganda Manuel M, Nouhou H, Nacoulma M, Mwaiselage J, Koulibaly M, Bayo S, Nsonde Malanda J, De Vuyst H, Herrero R, Sankaranarayanan R, Keita N; IARC Multicentre Study Group on Cervical Cancer Early Detection.

Cancer Causes Control. 2016 Dec;27(12):1437-1446. Epub 2016 Nov 7.

PMID:
27822586
5.

Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara.

Thera MA, Coulibaly D, Kone AK, Guindo AB, Traore K, Sall AH, Diarra I, Daou M, Traore IM, Tolo Y, Sissoko M, Niangaly A, Arama C, Baby M, Kouriba B, Sissoko MS, Sagara I, Toure OB, Dolo A, Diallo DA, Remarque E, Chilengi R, Noor R, Sesay S, Thomas A, Kocken CH, Faber BW, Imoukhuede EB, Leroy O, Doumbo OK.

Malar J. 2016 Aug 30;15(1):442. doi: 10.1186/s12936-016-1466-4.

6.

Distribution of FcγR gene polymorphisms among two sympatric populations in Mali: differing allele frequencies, associations with malariometric indices and implications for genetic susceptibility to malaria.

Cherif M, Amoako-Sakyi D, Dolo A, Pearson JO, Gyan B, Obiri-Yeboah D, Nebie I, Sirima SB, Doumbo O, Troye-Blomberg M, Bakary M.

Malar J. 2016 Jan 19;15:29. doi: 10.1186/s12936-015-1082-8.

7.

Genetic Resistance to Malaria Is Associated With Greater Enhancement of Immunoglobulin (Ig)M Than IgG Responses to a Broad Array of Plasmodium falciparum Antigens.

Arama C, Skinner J, Doumtabe D, Portugal S, Tran TM, Jain A, Traore B, Doumbo OK, Davies DH, Troye-Blomberg M, Dolo A, Felgner PL, Crompton PD.

Open Forum Infect Dis. 2015 Aug 26;2(3):ofv118. doi: 10.1093/ofid/ofv118. eCollection 2015 Sep.

8.

Genetic determinants of anti-malarial acquired immunity in a large multi-centre study.

Shelton JM, Corran P, Risley P, Silva N, Hubbart C, Jeffreys A, Rowlands K, Craik R, Cornelius V, Hensmann M, Molloy S, Sepulveda N, Clark TG, Band G, Clarke GM, Spencer CC, Kerasidou A, Campino S, Auburn S, Tall A, Ly AB, Mercereau-Puijalon O, Sakuntabhai A, Djimdé A, Maiga B, Touré O, Doumbo OK, Dolo A, Troye-Blomberg M, Mangano VD, Verra F, Modiano D, Bougouma E, Sirima SB, Ibrahim M, Hussain A, Eid N, Elzein A, Mohammed H, Elhassan A, Elhassan I, Williams TN, Ndila C, Macharia A, Marsh K, Manjurano A, Reyburn H, Lemnge M, Ishengoma D, Carter R, Karunaweera N, Fernando D, Dewasurendra R, Drakeley CJ, Riley EM, Kwiatkowski DP, Rockett KA; MalariaGEN Consortium.

Malar J. 2015 Aug 28;14:333. doi: 10.1186/s12936-015-0833-x.

9.

Safety, reactogenicity and immunogenicity of 2-dose catch-up vaccination with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children in the second year of life: Results from an open study.

Dicko A, Dicko Y, Barry A, Sidibe Y, Mahamar A, Santara G, Dolo A, Diallo A, Doumbo O, Shafi F, François N, Yarzabal JP, Strezova A, Borys D, Schuerman L.

Hum Vaccin Immunother. 2015;11(9):2207-14. doi: 10.1080/21645515.2015.1016679.

10.

Ethnic differences in susceptibility to malaria: what have we learned from immuno-epidemiological studies in West Africa?

Arama C, Maiga B, Dolo A, Kouriba B, Traoré B, Crompton PD, Pierce SK, Troye-Blomberg M, Miller LH, Doumbo OK.

Acta Trop. 2015 Jun;146:152-6. doi: 10.1016/j.actatropica.2015.03.023. Epub 2015 Mar 27. Review.

PMID:
25820030
11.

Is Fc gamma receptor IIA (FcγRIIA) polymorphism associated with clinical malaria and Plasmodium falciparum specific antibody levels in children from Burkina Faso?

Cherif MK, Sanou GS, Bougouma EC, Diarra A, Ouédraogo A, Dolo A, Troye-Blomberg M, Cavanagh DR, Theisen M, Modiano D, Sirima SB, Nebié I.

Acta Trop. 2015 Feb;142:41-6. doi: 10.1016/j.actatropica.2014.09.019. Epub 2014 Oct 31.

PMID:
25447268
12.

Glucose-6-phosphate dehydrogenase polymorphisms and susceptibility to mild malaria in Dogon and Fulani, Mali.

Maiga B, Dolo A, Campino S, Sepulveda N, Corran P, Rockett KA, Troye-Blomberg M, Doumbo OK, Clark TG.

Malar J. 2014 Jul 11;13:270. doi: 10.1186/1475-2875-13-270.

13.

[Frequency of glucose-6-phosphate dehydrogenase deficiency (A-376/202) in three Malian ethnic groups].

Dolo A, Maiga B, Guindo A, Diakité SA, Diakite M, Tapily A, Traoré M, Sangaré B, Arama C, Daou M, Doumbo O.

Bull Soc Pathol Exot. 2014 Aug;107(3):165-70. doi: 10.1007/s13149-014-0372-7. Epub 2014 Jun 20. French.

PMID:
24952161
14.

Patterns of malaria indices across three consecutive seasons in children in a highly endemic area of West Africa: a three times-repeated cross-sectional study.

Ardiet DL, Graz B, Szeless T, Mauris A, Falquet J, Doumbo OK, Dolo A, Guindo O, Sissoko MS, Konaré M, Motamed S, Rougemont AC.

Malar J. 2014 May 28;13:199. doi: 10.1186/1475-2875-13-199.

15.

[Non-neuromeningeal cryptococcosis in patients with AIDS in Bamako, Mali: 2 case reports].

Minta DK, Traoré AM, Coulibaly I, Diallo K, Soukho-Kaya A, Dolo A, Kamaté B, Ouologuem DS, Dembélé M, Traoré HA, Chabasse D, Pichard E.

J Mycol Med. 2014 Jun;24(2):e65-71. doi: 10.1016/j.mycmed.2013.11.003. Epub 2013 Dec 30. French.

PMID:
24387808
16.

Haptoglobin phenotype prevalence and cytokine profiles during Plasmodium falciparum infection in Dogon and Fulani ethnic groups living in Mali.

Perdijk O, Arama C, Giusti P, Maiga B, Troye-Blomberg M, Dolo A, Doumbo O, Persson JO, Boström S.

Malar J. 2013 Nov 25;12:432. doi: 10.1186/1475-2875-12-432.

17.

Extended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in malian children: 24-month follow-up of a randomized, double-blinded phase 2 trial.

Laurens MB, Thera MA, Coulibaly D, Ouattara A, Kone AK, Guindo AB, Traore K, Traore I, Kouriba B, Diallo DA, Diarra I, Daou M, Dolo A, Tolo Y, Sissoko MS, Niangaly A, Sissoko M, Takala-Harrison S, Lyke KE, Wu Y, Blackwelder WC, Godeaux O, Vekemans J, Dubois MC, Ballou WR, Cohen J, Dube T, Soisson L, Diggs CL, House B, Bennett JW, Lanar DE, Dutta S, Heppner DG, Plowe CV, Doumbo OK.

PLoS One. 2013 Nov 18;8(11):e79323. doi: 10.1371/journal.pone.0079323. eCollection 2013.

18.

Fc gamma receptor IIa-H131R polymorphism and malaria susceptibility in sympatric ethnic groups, Fulani and Dogon of Mali.

Maiga B, Dolo A, Touré O, Dara V, Tapily A, Campino S, Sepulveda N, Corran P, Rockett K, Clark TG, Blomberg MT, Doumbo OK.

Scand J Immunol. 2014 Jan;79(1):43-50. doi: 10.1111/sji.12122.

19.

Human candidate polymorphisms in sympatric ethnic groups differing in malaria susceptibility in Mali.

Maiga B, Dolo A, Touré O, Dara V, Tapily A, Campino S, Sepulveda N, Risley P, Silva N, Corran P, Rockett KA, Kwiatkowski D; MalariaGEN Consortium, Clark TG, Troye-Blomberg M, Doumbo OK.

PLoS One. 2013 Oct 2;8(10):e75675. doi: 10.1371/journal.pone.0075675. eCollection 2013. Erratum in: PLoS One. 2014;9(7):e104358. Silva, Nipula [corrected to Silva, Nilupa].

20.

Inter-observer agreement according to malaria parasite density.

Billo MA, Diakité M, Dolo A, Diallo M, Poudiougou B, Diawara SI, Johnson ES, Rice JC, Krogstad DJ, Doumbo OK.

Malar J. 2013 Sep 22;12:335. doi: 10.1186/1475-2875-12-335.

21.

Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children.

Dicko A, Santara G, Mahamar A, Sidibe Y, Barry A, Dicko Y, Diallo A, Dolo A, Doumbo O, Shafi F, François N, Strezova A, Borys D, Schuerman L.

Hum Vaccin Immunother. 2013 Feb;9(2):382-8. Epub 2013 Jan 4.

22.

[Reduction Of Maternal And Neonatal Mortality Due To Free Caesarean In Segou's Nianankoro Fomba Hospital In Mali].

Thera T, Teguete I, Traore Y, Kouma A, Traore B, Kokaina C, Dolo T, Samassa BL, Traore M, Dolo A.

Mali Med. 2013;28(2):53-57. French.

PMID:
30049093
23.

[Reference values of neonatal erythrocyte and leukocyte count in Bamako, Mali].

Diallo DA, Diawara F, Guindo A, Touré M, Traoré M, Fofana AT, Dembélé AK, Guindo A, Diallo YL, Diallo O, Baraika AM, Dolo AI.

Mali Med. 2013;28(1):36-43. French.

PMID:
29925219
24.

[Relationship between malaria and anemia in two ethnic groups living in sympatry in Mali].

Dolo A, Maiga B, Tolo Y, Tapily A, Arama C, Daou M, Baby M, Traore B, Doumbo O.

Bull Soc Pathol Exot. 2012 Dec;105(5):370-6. doi: 10.1007/s13149-012-0265-6. Epub 2012 Oct 10. French.

PMID:
23055385
25.

[Humoral immune anti-Plasmodium falciparum AMA1 and MSP1 response in two ethnic groups living in sympatry in Mali].

Dolo A, Coulibaly M, Maïga B, Daou M, Arama C, Troye-Blomberg M, Doumbo O.

Bull Soc Pathol Exot. 2012 Dec;105(5):364-9. doi: 10.1007/s13149-012-0262-9. Epub 2012 Oct 10. French.

PMID:
23055382
26.

[Place of malaria among febrile illnesses in two ethnic tribes living in sympatry in Mali from 1998 to 2008].

Dolo A, Maïga B, Dara V, Tapily A, Tolo Y, Arama C, Daou M, Doumbo O.

Bull Soc Pathol Exot. 2012 Dec;105(5):377-83. doi: 10.1007/s13149-012-0249-6. Epub 2012 Aug 29. French.

PMID:
22932999
27.

B cell analysis of ethnic groups in Mali with differential susceptibility to malaria.

Portugal S, Doumtabe D, Traore B, Miller LH, Troye-Blomberg M, Doumbo OK, Dolo A, Pierce SK, Crompton PD.

Malar J. 2012 May 11;11:162. doi: 10.1186/1475-2875-11-162.

28.

Changes in the levels of cytokines, chemokines and malaria-specific antibodies in response to Plasmodium falciparum infection in children living in sympatry in Mali.

Boström S, Giusti P, Arama C, Persson JO, Dara V, Traore B, Dolo A, Doumbo O, Troye-Blomberg M.

Malar J. 2012 Apr 5;11:109. doi: 10.1186/1475-2875-11-109.

29.

[Neuromeningeal cryptococcosis in Mali].

Minta DK, Dolo A, Dembele M, Kaya AS, Sidibe AT, Coulibaly I, Maiga II, Diallo M, Traore AM, Maiga MY, Doumbo OK, Traore HA, Pichard E, Chabasse D.

Med Trop (Mars). 2011 Dec;71(6):591-5. French.

PMID:
22393627
30.

False-negative rapid diagnostic tests for malaria and deletion of the histidine-rich repeat region of the hrp2 gene.

Koita OA, Doumbo OK, Ouattara A, Tall LK, Konaré A, Diakité M, Diallo M, Sagara I, Masinde GL, Doumbo SN, Dolo A, Tounkara A, Traoré I, Krogstad DJ.

Am J Trop Med Hyg. 2012 Feb;86(2):194-8. doi: 10.4269/ajtmh.2012.10-0665.

31.

Haematological parameters, natural regulatory CD4 + CD25 + FOXP3+ T cells and γδ T cells among two sympatric ethnic groups having different susceptibility to malaria in Burkina Faso.

Sanou GS, Tiendrebeogo RW, Ouédraogo AL, Diarra A, Ouédraogo A, Yaro JB, Ouédraogo E, Verra F, Behr C, Troye-Blomberg M, Modiano D, Dolo A, Torcia MG, Traoré Y, Sirima SB, Nébié I.

BMC Res Notes. 2012 Jan 27;5:76. doi: 10.1186/1756-0500-5-76.

32.

FcγRIIa polymorphism and anti-malaria-specific IgG and IgG subclass responses in populations differing in susceptibility to malaria in Burkina Faso.

Cherif MK, Sanou GS, Maiga B, Israelsson E, Ouédraogo AL, Bougouma EC, Diarra A, Ouédraogo A, Ouattara AS, Troye-Blomberg M, Dolo A, Cavanagh DR, Theisen M, Modiano D, Sirima SB, Nebié I.

Scand J Immunol. 2012 Jun;75(6):606-13. doi: 10.1111/j.1365-3083.2012.02690.x.

33.

Primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in infants in Mali and Nigeria: a randomized controlled trial.

Dicko A, Odusanya OO, Diallo AI, Santara G, Barry A, Dolo A, Diallo A, Kuyinu YA, Kehinde OA, François N, Borys D, Yarzabal JP, Moreira M, Schuerman L.

BMC Public Health. 2011 Nov 23;11:882. doi: 10.1186/1471-2458-11-882.

34.

A field trial to assess a blood-stage malaria vaccine.

Thera MA, Doumbo OK, Coulibaly D, Laurens MB, Ouattara A, Kone AK, Guindo AB, Traore K, Traore I, Kouriba B, Diallo DA, Diarra I, Daou M, Dolo A, Tolo Y, Sissoko MS, Niangaly A, Sissoko M, Takala-Harrison S, Lyke KE, Wu Y, Blackwelder WC, Godeaux O, Vekemans J, Dubois MC, Ballou WR, Cohen J, Thompson D, Dube T, Soisson L, Diggs CL, House B, Lanar DE, Dutta S, Heppner DG Jr, Plowe CV.

N Engl J Med. 2011 Sep 15;365(11):1004-13. doi: 10.1056/NEJMoa1008115.

35.

Can visual cervical screening be sustained in routine health services? Experience from Mali, Africa.

Teguete I, Muwonge R, Traore CB, Dolo A, Bayo S, Sankaranarayanan R.

BJOG. 2012 Jan;119(2):220-6. doi: 10.1111/j.1471-0528.2011.03122.x. Epub 2011 Sep 6.

36.

[Blood supply and demand at the Fifth District Health Centre in Bamako (Mali)].

Traore M, Dumont A, Kaya AB, Traore SO, Traore OM, Dolo A.

Sante. 2011 Jan-Mar;21(1):33-40. doi: 10.1684/san.2011.0237. French.

37.

Cytokine gene haplotypes with a potential effect on susceptibility to malaria in sympatric ethnic groups in Mali.

Israelsson E, Maiga B, Kearsley S, Dolo A, Homann MV, Doumbo OK, Troye-Blomberg M, Tornvall P, Berzins K.

Infect Genet Evol. 2011 Oct;11(7):1608-15. doi: 10.1016/j.meegid.2011.05.021. Epub 2011 Jun 25.

PMID:
21708291
38.

Interethnic differences in antigen-presenting cell activation and TLR responses in Malian children during Plasmodium falciparum malaria.

Arama C, Giusti P, Boström S, Dara V, Traore B, Dolo A, Doumbo O, Varani S, Troye-Blomberg M.

PLoS One. 2011 Mar 31;6(3):e18319. doi: 10.1371/journal.pone.0018319.

39.

Lactase persistence genotypes and malaria susceptibility in Fulani of Mali.

Lokki AI, Järvelä I, Israelsson E, Maiga B, Troye-Blomberg M, Dolo A, Doumbo OK, Meri S, Holmberg V.

Malar J. 2011 Jan 14;10:9. doi: 10.1186/1475-2875-10-9.

40.

[Twin pregnancy after tubal ligation: case report].

Traoré M, Traoré SO, Traoré OM, Maïga MA, Sy I, Dolo A.

Mali Med. 2011;26(3):56-7. French.

PMID:
22977891
42.

[Epidemiogic and clinical profile of severe pre-eclampsia at the university hospital of Gabriel Touré].

Samaké BM, Traoré M, Goita L, Niani M, Traoré Y, Teketé I, Diallo A, Dolo A.

Mali Med. 2011;26(4):5-7. French.

PMID:
22766499
43.

[Stillbirths in the department of Obstetrics and Gynecology of the Health Center of Refers Common V (CSRef CV) of the district of Bamako].

Traoré M, Traoré SO, Traoré OM, Traoré S, Dolo A.

Mali Med. 2011;26(3):41-4. French.

PMID:
22766376
44.

[Prevention of mother to child HIV transmission in an African hospital, Bamako-Mali].

Traore Y, Dicko Traore F, Teguete I, Mounkoro N, Thera A, Sissoko A, Diallo A, Dolo T, Bagayogo M, Djire YM, Kone D, Doumbia D, Kone O, Tinfa L, Sofara A, Sylla M, Traore M, Diop AB, Diop O, Dolo A.

Mali Med. 2011;26(1):18-22. French.

PMID:
22766239
45.

Memory-like IFN-γ response by NK cells following malaria infection reveals the crucial role of T cells in NK cell activation by P. falciparum.

McCall MB, Roestenberg M, Ploemen I, Teirlinck A, Hopman J, de Mast Q, Dolo A, Doumbo OK, Luty A, van der Ven AJ, Hermsen CC, Sauerwein RW.

Eur J Immunol. 2010 Dec;40(12):3472-7. doi: 10.1002/eji.201040587.

46.

[Immunity in human schistosomiasis: hope for a vaccine].

Kouriba B, Traore B, Diemert D, Thera MA, Dolo A, Tounkara A, Doumbo O.

Med Trop (Mars). 2010 Apr;70(2):189-97. Review. French.

PMID:
20486361
47.

[Obstacles to laboratory diagnosis of malaria in Mali--perspectives].

Dolo A, Diallo M, Saye R, Konaré A, Ouattara A, Poudiougo B, Kouyaté B, Minta D, Doumbo OK.

Med Trop (Mars). 2010 Apr;70(2):158-62. French.

PMID:
20486352
48.

Persistence of full-length caspase-12 and its relation to malaria in West and Central African populations.

McCall MB, Ferwerda B, Hopman J, Ploemen I, Maiga B, Daou M, Dolo A, Hermsen CC, Doumbo OK, Bedu-Addo G, van der Meer JW, Troye-Blomberg M, van der Ven AJ, Schumann RR, Sauerwein RW, Mockenhaupt FP, Netea MG.

Eur Cytokine Netw. 2010 Jun;21(2):77-83. doi: 10.1684/ecn.2010.0187. Epub 2010 Apr 27.

49.

Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial.

Thera MA, Doumbo OK, Coulibaly D, Laurens MB, Kone AK, Guindo AB, Traore K, Sissoko M, Diallo DA, Diarra I, Kouriba B, Daou M, Dolo A, Baby M, Sissoko MS, Sagara I, Niangaly A, Traore I, Olotu A, Godeaux O, Leach A, Dubois MC, Ballou WR, Cohen J, Thompson D, Dube T, Soisson L, Diggs CL, Takala SL, Lyke KE, House B, Lanar DE, Dutta S, Heppner DG, Plowe CV.

PLoS One. 2010 Feb 4;5(2):e9041. doi: 10.1371/journal.pone.0009041.

50.

A molecular map of chloroquine resistance in Mali.

Djimde AA, Barger B, Kone A, Beavogui AH, Tekete M, Fofana B, Dara A, Maiga H, Dembele D, Toure S, Dama S, Ouologuem D, Sangare CP, Dolo A, Sogoba N, Nimaga K, Kone Y, Doumbo OK.

FEMS Immunol Med Microbiol. 2010 Feb;58(1):113-8. doi: 10.1111/j.1574-695X.2009.00641.x. Epub 2009 Nov 2.

Supplemental Content

Support Center